Beating Cancer Inequalities in the EU – An OECD Report Summary Cancer is a significant health problem in Europe. It is estimated that every 5 minutes, a person is diagnosed with a type of cancer. It is expected […]

Health Data and Pharma Package Move Forward One cannot deny that the European legislative process might be tedious and cumbersome, but there is nothing like a bit of drama in last-minute deals […]

DiCE Collaborates with GCCA and FUTEJE Towards Improving CRC in Mexico At DiCE, our commitment to supporting patients affected by Colorectal Cancer knows no boundaries. That’s why we are thrilled to share our recent […]

OECD Report Confirms Inequalities in Cancer OECD, in cooperation with the European Commission, published the latest data on cancer in the EU27, Norway and Iceland (EU+2). The report addresses […]

European Commission is Looking for Experts in CRC The European Commission is looking for experts in CRC (pathology, radiation oncology and nursing). The main objective of the European Commission […]

Positive Response to New Neoadjuvant Treatment Combination for Gastric and Gastroesophageal Cancer Despite advances in treatment options, most patients diagnosed with non-metastatic((cancer that has not yet spread to other organs) gastric or […]

Biomarkers and their Role in the Diagnosis and Treatment of Cholangiocarcinoma (CCA) What is CCA? Cholangiocarcinoma (CCA) is a cancer that starts in the biliary tract. The biliary tract includes the liver, gallbladder and bile […]

COR2ED’s New Resources on Advanced HCC COR2ED is an independent medical education company that develops impactful educational programmes within specific therapeutic areas. They have […]

WECAN Evidence-Based Advocacy Workshop From 17-19 January, Lāsma Nikolaisone, a patient advocate from “Onkoalianse”, a member organisation of Digestive Cancers Europe in Latvia, had the […]

Lynch Syndrome, the Most Common of the Rarest 22 March is Lynch Syndrome Day, also known as Hereditary Non-Polyposis Colorectal Cancer, so we will remind people that those who have Lynch […]

ASCO GI Highlights – Positive Data in Earlier Stage HCC Results The American Society for Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI) was held in San Francisco, USA 18-20 January this year. At […]

Gemcitabine Plus Paclitaxel vs Gemcitabine Alone after FOLFIRINOX in Metastatic Pancreatic Cancer GEMPAX was an open-label (both researchers and patients know which treatment is being administered), randomised (randomly assigns participants i […]

European Union Steps Up its Efforts to Eliminate Liver Cancer The European Commission presented Recommendations to support Members States in their efforts to prevent cancer through vaccination, it is a part of […]

Celebrating a Lifetime of Achievement: Dr Eric Van Cutsem Honoured as Professor Emeritus Dr Eric Van Cutsem, world-renowned Professor of Clinical Digestive Oncology and co-founder of Digestive Cancers Europe, was lauded as Professor […]

Educational Booklets For Togas Pilot Studies Participants Are Now Available Gastric cancer is the fourth most common cause of cancer-related deaths worldwide and is the fifth most frequently diagnosed cancer. It accounts for […]